Patents by Inventor Kai Long

Kai Long has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted pyrimido[1,6-a]pyrimidines as Lp-PLAinhibitors
    Patent number: 9273054
    Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: March 1, 2016
    Assignee: Glaxo Group Limited
    Inventors: Zehong Wan, Kai Long, Xiaomin Zhang, Haihua Yu
  • 2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors
    Patent number: 8975400
    Abstract: Disclosed are 2,3-dihydroimiazo[1,2-c]pyrimidin-5(IH)-one compounds that inhibit Lp-PLA2,processes for their preparation, compositions containing them and their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: March 10, 2015
    Assignee: Glaxo Group Limited
    Inventors: Zehong Wan, Kai Long, Yingxia Sang, Xiaobo Su
  • TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES
    Publication number: 20140378487
    Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Inventors: Zehong Wan, Xiaomin Zhang, Zhaolong Tong, Kai Long, Saiah E. Dowdell, Eric Steven Manas, Krista Beaver Goodman
  • Tricyclic compounds, preparation methods, and their uses
    Patent number: 8871928
    Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: October 28, 2014
    Assignee: Glaxo Group Limited
    Inventors: Zehong Wan, Xiaomin Zhang, Zhaolong Tong, Kai Long, Sarah E. Dowdell, Eric Steven Manas, Krista Beaver Goodman
  • 2,3-DIHYDROIMIDAZO[1 ,2-c] PYRIMIDIN-5(1 H)-ONE COMPOUNDS USE AS LP-PLA2 INHIBITORS
    Publication number: 20140179715
    Abstract: Disclosed are 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one compounds that inhibit Lp-PLA2, processes for their preparation, compositions containing them and their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
    Type: Application
    Filed: July 25, 2012
    Publication date: June 26, 2014
    Applicant: Glaxo Group Limited
    Inventors: Zehong Wan, Kai Long, Yingxia Sang, Xiaobo Su
  • BICYCLIC PYRIMIDONE COMPOUNDS
    Publication number: 20140179716
    Abstract: The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
    Type: Application
    Filed: July 25, 2012
    Publication date: June 26, 2014
    Inventors: Zehong Wan, Kai Long, Xiaomin Zhang, Haihua Yu
  • TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES
    Publication number: 20130178488
    Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.
    Type: Application
    Filed: September 20, 2011
    Publication date: July 11, 2013
    Inventors: Zehong WAN, Xiaomio Zhang, Zhaolong Tong, Kai Long, Sarah E. Dowdell, Eric Steven Manas, Krista Beaver Goodman
  • COMPOUNDS
    Publication number: 20130030012
    Abstract: The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
    Type: Application
    Filed: July 25, 2012
    Publication date: January 31, 2013
    Applicant: Glaxo Group Limited
    Inventors: Kai Long, Zehong Wan
  • Innerspring Unit
    Publication number: 20080237948
    Abstract: An improved manufacturing of innerspring unit for a mattress is disclosed comprises the innerspring rows and columns of coil springs connected to each other with helical wires. An independent suspension, namely the pocket spring, is installed at the center porting of the innerspring to provide additional suspension support to the heaviest part of the body, namely the hips portion, while in sleeping position.
    Type: Application
    Filed: October 11, 2005
    Publication date: October 2, 2008
    Inventor: Tan Kai Long
  • Computerized virtual paint manufacturing and application system
    Patent number: 6330487
    Abstract: A computer-implemented apparatus and method for coordinating paint-related process steps of at least one paint-related facility. The paint-related process steps exhibit paint-related characteristics. A data acquisition module is provided for acquiring paint characteristic data indicative of the paint-related characteristics. A paint process control data structure is provided for interrelating the acquired paint characteristic data with at least two of the paint-related process steps to produce interrelated paint process control data. A paint process control coordinator is connected to the data acquisition module for storing the acquired paint characteristic data in the paint process control data structure. A data display is connected to the paint process control data structure for remotely receiving and viewing the interrelated paint process control data.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: December 11, 2001
    Inventors: Raimar A. Jahn, Edward A. Guerrini, Paul E. Lamberty, Christopher T. Dine, Aimee Barach, Kai Long, Dirk Nimphius, Jürgen Pitzer
  • Computerized virtual paint manufacturing and application system
    Patent number: 6073055
    Abstract: A computer-implemented apparatus and method for coordinating paint-related process steps of at least one paint-related facility. The paint-related process steps exhibit paint-related characteristics. A data acquisition module is provided for acquiring paint characteristic data indicative of the paint-related characteristics. A paint process control data structure is provided for interrelating the acquired paint characteristic data with at least two of the paint-related process steps to produce interrelated paint process control data. A paint process control coordinator is connected to the data acquisition module for storing the acquired paint characteristic data in the paint process control data structure. A data display is connected to the paint process control data structure for remotely receiving and viewing the interrelated paint process control data.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: June 6, 2000
    Assignee: BASF Corporation
    Inventors: Raimar A. Jahn, Edward A. Guerrini, Paul E. Lamberty, Christopher T. Dine, Aimee Barach, Kai Long, Dirk Nimphius, Jurgen Pitzer